ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 4186 - 4200 of 5996 products
TaiGen Reports Positive Taiwan-China Data for Novel Antibiotic
$5.00
Available
Eisai Pays $78 Million to Acquire Small China Generic Drugmaker
$5.00
Available
Tigermed Expands: Buys Korean CRO and Builds China Central Lab
$5.00
Available
3SBio Acquires Control of CP Guojian in $213 Million Deal
$5.00
Available
Sinopharm Affiliate Pays $50 Million for Oramed's Oral Insulin Product
$5.00
Available
Meinian Onehealth Tops Management's Offer for iKang Healthcare
$5.00
Available
BGI Changes Direction at Complete Genomics; Cuts Staff
$5.00
Available
Uni-Bio Science Acquires Rights to Jiangsu Hansoh's Diabetes Drug
$5.00
Available
Lee's Pharma to Market Solasia's Anti-Nausea Patch in China
$5.00
Available
Shenzhen Hepalink Invests $13 Million in Canada's OncoQuest
$5.00
Available
ZAI Lab Acquires China Rights to Hanmi Lung Cancer Drug
$5.00
Available
China's Spending for Drugs to Rise 6-9% during 2016-2020: IMS
$5.00
Available
Nantong Jinghua In-licenses Two Cancer mAbs for $50 Million
$5.00
Available
Tianjin Tasly Starts $784 Million China Healthcare Fund
$5.00
Available
Fresenius Opens Shanghai R&D Center for Renal Products
$5.00
Available